Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND. SWIFT vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IND. SWIFT   MYLAN
EQUITY SHARE DATA
    IND. SWIFT
Mar-23
MYLAN
Dec-18
IND. SWIFT/
MYLAN
5-Yr Chart
Click to enlarge
High Rs153,978-   
Low Rs72,190-   
Sales per share (Unadj.) Rs75.91,830.6-  
Earnings per share (Unadj.) Rs4.849.7-  
Cash flow per share (Unadj.) Rs10.1392.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-130.11,980.4-  
Shares outstanding (eoy) m54.16514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.11.7 8.3%   
Avg P/E ratio x2.262.0 3.5%  
P/CF ratio (eoy) x1.07.9 13.3%  
Price / Book Value ratio x-0.11.6 -5.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m5721,586,770 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m6370-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m4,110941,863 0.4%  
Other income Rs m1190-   
Total revenues Rs m4,228941,863 0.4%   
Gross profit Rs m1,026243,719 0.4%  
Depreciation Rs m287176,354 0.2%   
Interest Rs m59845,300 1.3%   
Profit before tax Rs m26022,065 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-3,510 -0.0%   
Profit after tax Rs m26025,575 1.0%  
Gross profit margin %25.025.9 96.5%  
Effective tax rate %0-15.9 -0.0%   
Net profit margin %6.32.7 233.3%  
BALANCE SHEET DATA
Current assets Rs m2,734525,936 0.5%   
Current liabilities Rs m9,363383,465 2.4%   
Net working cap to sales %-161.315.1 -1,066.5%  
Current ratio x0.31.4 21.3%  
Inventory Days Days11584 137.8%  
Debtors Days Days92993 995.4%  
Net fixed assets Rs m3,758182,706 2.1%   
Share capital Rs m108501 21.6%   
"Free" reserves Rs m-7,1550-   
Net worth Rs m-7,0471,018,924 -0.7%   
Long term debt Rs m4,0311,099,746 0.4%   
Total assets Rs m6,4922,733,150 0.2%  
Interest coverage x1.41.5 96.5%   
Debt to equity ratio x-0.61.1 -53.0%  
Sales to assets ratio x0.60.3 183.7%   
Return on assets %13.22.6 509.6%  
Return on equity %-3.72.5 -147.2%  
Return on capital %-28.43.2 -894.7%  
Exports to sales %68.80-   
Imports to sales %5.30-   
Net fx Rs m2,6340-   
CASH FLOW
From Operations Rs m730195,719 0.4%  
From Investments Rs m-293-101,165 0.3%  
From Financial Activity Rs m-466-91,177 0.5%  
Net Cashflow Rs m-291,621 -1.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare IND. SWIFT With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IND. SWIFT With: SOLARA ACTIVE PHARMA SCIENCES  VEERHEALTH CARE  JFL LIFE SCIENCES LTD.  DR. REDDYS LAB  UNJHA FORMUL  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.